Botulinum toxin A as a treatment modality for acute acquired comitant esotropia – An Indian perspective
Purpose: To analyze the outcomes of botulinum toxin A injection in acute acquired comitant esotropia (AACE). Methods: This is a retrospective study that included cases diagnosed as AACE between January 2022 and February 2023. Patients who were treated with Botox and completed a minimum 3 months foll...
Saved in:
Main Authors: | Akshay Badakere, Vibha Badrinath, Hennaav Kaur Dhillon, Abinaya Valliappan, Viswanathan Natarajan, Sumita Agarkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-02-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/IJO.IJO_2198_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Botulinum toxin-A in acute acquired comitant esotropia during COVID pandemic in children and young adolescents
by: Neelam Pawar, et al.
Published: (2025-02-01) -
Horizontal rectus muscle insertion sites in patients with infantile esotropia and acute acquired concomitant esotropia
by: Shuyuan Liao, et al.
Published: (2025-01-01) -
Iatrogenic Botulism After Cosmetic Use of Botulinum Toxin‐A: A Case Series
by: Mohammad Asadi, et al.
Published: (2025-01-01) -
Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort
by: Gabrielle French, et al.
Published: (2020-01-01) -
Patient-centred evaluation of a reduced dose of botulinum toxin A in the management of myofascial pain
by: Alice Cameron, et al.
Published: (2025-03-01)